Profil
Alberto Mas is currently the President of Accuri Cytometers, Inc. Previously, he held the position of Executive VP & President-Medical Segment at Becton, Dickinson & Co.
Postes actifs de Alberto Mas
| Sociétés | Poste | Début |
|---|---|---|
Accuri Cytometers, Inc.
 Accuri Cytometers, Inc. Medical SpecialtiesHealth Technology Accuri Cytometers, Inc. develops and manufactures personal flow cytometers for researchers. It operates as a life sciences company which develops and markets high performance cell analysis systems designed to bring the power of flow cytometry into life science and biomedical laboratories. The firm offers C6 Flow Cytometer, a bench-top cell and bead analysis system used in various applications, such as immunophenotyping, bacteria analysis, cell cycle analysis, proliferation assays, apoptosis, DNA analysis, target multiplexing, gene expression, lineage analysis, viability, absolute cell counts, intracellular cytokines, membrane potential, yeast and algae analysis, and phagocytosis. The company was founded by Jennifer A. Baird and Collin A. Rich in 2004 and is headquartered in Ann Arbor, MI. | President | - |
Anciens postes connus de Alberto Mas
| Sociétés | Poste | Fin |
|---|---|---|
| BECTON, DICKINSON AND COMPANY | Corporate Officer/Principal | 01/07/2022 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BECTON, DICKINSON AND COMPANY | Health Technology |
| Entreprise privées | 1 |
|---|---|
Accuri Cytometers, Inc.
Accuri Cytometers, Inc. Medical SpecialtiesHealth Technology Accuri Cytometers, Inc. develops and manufactures personal flow cytometers for researchers. It operates as a life sciences company which develops and markets high performance cell analysis systems designed to bring the power of flow cytometry into life science and biomedical laboratories. The firm offers C6 Flow Cytometer, a bench-top cell and bead analysis system used in various applications, such as immunophenotyping, bacteria analysis, cell cycle analysis, proliferation assays, apoptosis, DNA analysis, target multiplexing, gene expression, lineage analysis, viability, absolute cell counts, intracellular cytokines, membrane potential, yeast and algae analysis, and phagocytosis. The company was founded by Jennifer A. Baird and Collin A. Rich in 2004 and is headquartered in Ann Arbor, MI. | Health Technology |
